• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  03/06/2014
Trade Name:  Revatio
Generic Name or Proper Name (*):  sildenafil
Indications Studied:  Treatment of pulmonary arterial hypertension (PAH)
Label Changes Summary:  *Labeling updated to include information on results of an open-label pediatric safety extension study* During the study, there were 42 deaths with 37 of these deaths reported prior to a decision to titrate patients to a lower dosage because of a finding of increased mortality. An increase in mortality was observed with increasing doses *Causes of death in the extension study were typical of patients with PAH
Product Labeling:  Labeling  Opens a new window
Sponsor:  Pfizer
Pediatric Exclusivity Granted Date:  02/09/2012
Therapeutic Category:  Peripheral vasodilator